Association of vitamin D receptor gene polymorphism and risk of prostate cancer in India

Urologia Internationalis

Volumn 74, Issue 4, 2005, Pages 315-318

  Mishra, Dhruva Kumar ^a   Bid, Hemant Kumar ^a   Srivastava, Daya Shankar Lal ^a   Mandhani, Anil ^a   Mittal, Rama Devi ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Polymerase chain reaction restriction fragment length polymorphism; Prostate cancer; Single nucleotide polymorphisms; Vitamin D receptor (Fok 1) polymorphism

Indexed keywords

GENE PRODUCT; VITAMIN D RECEPTOR;

ADULT; AGED; ALLELE; ARTICLE; CANCER PATIENT; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GLEASON SCORE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PRIORITY JOURNAL; PROSTATE CANCER; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RESTRICTION SITE; STATISTICAL SIGNIFICANCE;

GENE FREQUENCY; GENETIC MARKERS; GENOTYPE; HUMANS; INDIA; MALE; POLYMORPHISM, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, CALCITRIOL; RISK;

EID: 20844438206     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084429     Document Type: Article

References (13)

1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ: Cancer statistics, 2003. CA Cancer J Clin 2003;53:5-26.
2. Schulz WA, Burchardt M, Cronauer MV: Molecular biology of prostate cancer. Mol Hum Reprod 2003;9:437-448.
3. Corder EH, Guess HA, Hulka BS, Friedman GD, Sadler M, Vollmer RT, Lobaugh B, Drezner MK, Vogelman JH, Orentreich N: Vitamin D and prostate cancer: A prediagnostic study with stored sera. Cancer Epidemiol Biolmarkers Prev 1993;2:467-472.
4. Zmuda JM, Cauley JA, Ferrel RE: Molecular epidemiology of vitamin D receptor gene variants. Epidemiol Rev 2000;22:203-217.
5. Xu Y, Shibata A, John EM, Stamey TA, Feldman D, Peehl DM: Vitamin D receptor start codon polymorphism (Fok1) and prostate cancer progression. Cancer Epidemiol Biomarkers Prev 2003;12:23-27.
6. Correa-Cerro L, Berthon P, Haussler J, Bochum S, Drelon E, Mangin P, Fournier G, Paiss T, Cussenot O, Vogel W: Vitamin D receptor polymorphisms as markers in prostate cancer. Hum Genet 1999;105:281-287.
7. Harris SS, Eccleshall TR, Gross C, et al: The vitamin D receptor start codon polymorphism (Fok-1) and bone mineral density in premenopausal American Black and White women. J Bone Miner Res 1997;12:1043-1048.
8. Bernstein L, Ross RK: Cancer in Los Angeles County: A Portrait of Incidence and Mortality. Los Angles, University of Southern California Press, 1991.
9. Jurutka PW, Remus LS, Whitfield GK, Thompson PD, Hsieh JC, Zitzer H, Tavakkoli P, Galligan MA, Dang HT, Haussler CA, Haussler MR: The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor II B. Mol Endocrinol 2000;14:401-420.
10. Yang Y, Wang S, Ye Z, Yang W: Association of single nucleotide polymorphism of vitamin D receptor gene start codon and the susceptibility to prostate cancer in the Han nationality in Hubei area. Zhonghua Nan Ko Xuo 2004;10:411-414.
11. Ingles SA, Haile RW, Henderson BE, Kolnel LN, Nakaichi G, Shi CY, Yu MC, Ross RK, Coetzee GA: Strength in linkage disequilibrium between two vitamin D receptor markers in five ethnic groups: Implications for association studies. Cancer Epidemiol Biomarkers Prev 1997;6:93-98.
12. Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, Haussler CA, Galligan MA, Thatcher ML, Encinas Dominguez C, Haussler MR: Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol 2001;177:145-159.
13. Chokkalingam AP, McGlynn KA, Gao YT, Pollak M, Deng J, Sesterhenn IA, Mostofi FK, Fraumeni JF Jr, Hsing AW: Vitamin D receptor gene polymorphisms, insulin-like growth factors and prostate cancer risk: A population-based case-control study in China. Cancer Res 2001;61:4333-4336.